Results 151 to 160 of about 55,598 (274)

Blood flow differences in cun-kou (radial) artery and anterior tibial artery: normal people vs patients with chronic gastritis

, 2018
Chao Wang, Yun Wei, Lin Zhang, Jia Song, Ni Liu, Yanling Fu   +5 more
openalex   +1 more source

S3 Guideline for the treatment of psoriasis vulgaris, adapted from EuroGuiDerm – part 1: Treatment recommendations and monitoring

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 1, Page 122-137, January 2026.
Summary This first part of the updated German S3 guideline on the treatment of psoriasis vulgaris covers the sections on treatment recommendations, treatment goals, and monitoring of therapies. The recommendations are based on the current Cochrane network meta‐analysis, the results of which are also summarized.
Alexander Nast, Andreas Altenburg, Matthias Augustin, Frank Bachmann, Wolf‐Henning Boehncke, Markus Cornberg, Hilte Geerdes‐Fenge, Brit Häcker, Peter Härle, Joachim Klaus, Michaela Köhm, Arno Köllner, Ulrich Mrowietz, Hans‐Michael Ockenfels, Antonia Pennitz, Sandra Philipp, Thomas Richter, Thomas Rosenbach, Tom Schaberg, Martin Schlaeger, Gerhard Schmid‐Ott, Michael Sebastian, Karisa Thölken, Ralph von Kiedrowski, Uwe Willuhn, Christoph Zeyen   +25 more
wiley   +1 more source

Diagnostic value of combined detection of pepsinogen, gastrin-17, and ¹³C-urea breath test in Helicobacter pylori-associated chronic gastritis in children: a multivariate analysis. [PDF]

Front Pediatr
Gao Y, Liu C, Ouyang K, Li S, Huang W.
europepmc   +1 more source

Helicobacter pylori infection altered gastric microbiota in patients with chronic gastritis. [PDF]

Front Cell Infect Microbiol, 2023
Hua Z, Xu L, Zhu J, Xiao L, Lu B, Wu J, Wu Z, Zhou Q, Zhang J.   +8 more
europepmc   +1 more source

DETECTION OF HELICOBACTER PYLORI INFECTION IN CHRONIC GASTRITIS BIOPSY SPECIMEN USING WARTHIN-STARRY AND MODIFIED GIEMSA STAIN IN DR SOETOMO HOSPITAL SURABAYA

, 2019
Willy Sandhika
openalex   +2 more sources

Relative efficacy of GLP‐1 and GLP‐1/GIP receptor agonists in the prevention of alcohol‐use disorders using a target trial emulation approach

Diabetes, Obesity and Metabolism, Volume 28, Issue 1, Page 137-150, January 2026.
Abstract Aims There is growing evidence that the GLP‐1 system is implicated in alcohol and other substance use disorders, and that GLP‐1‐based therapies may have therapeutic relevance in alcohol use disorder (AUD). We aimed to determine the impact of GLP‐1 based therapies on incident AUDs in a real‐world setting in patients with T2D.
Alex E. Henney, David R. Riley, Megan Heague, Carl A. Roberts, Theresa J. Hydes, Matthew Anson, David M. Hughes, Uazman Alam, Daniel J. Cuthbertson   +8 more
wiley   +1 more source

GastritisMIL: An interpretable deep learning model for the comprehensive histological assessment of chronic gastritis. [PDF]

Patterns (N Y)
Xia K, Hu Y, Cai S, Lin M, Lu M, Lu H, Ye Y, Lin F, Gao L, Xia Q, Tian R, Lin W, Xie L, Tan D, Lu Y, Lin X, Yang X, Zhong L, Xu L, Zhang Z, Wang L, Ren J, Xu H.   +22 more
europepmc   +1 more source

Treatment of Chronic Gastritis with Traditional Chinese Medicine: Pharmacological Activities and Mechanisms. [PDF]

Pharmaceuticals (Basel), 2023
Chen L, Wei S, He Y, Wang X, He T, Zhang A, Jing M, Li H, Wang R, Zhao Y.   +9 more
europepmc   +1 more source

Difference in chromatin sensitivity to heparin of chronic atrophic gastritis, of carcinoma‐free and carcinoma‐bearing stomach in comparison with normal gastric mucosa and gastric carcinoma as revealed by flow cytometry [PDF]

, 1983
H. Weiß, U. Heinz, Herbert Gütz, W. Schälicke   +3 more
openalex   +1 more source

Lobeglitazone improves glycaemic control as add‐on therapy to empagliflozin plus metformin in patients with type 2 diabetes mellitus: A double‐blind, randomised, placebo‐controlled trial

Diabetes, Obesity and Metabolism, Volume 28, Issue 1, Page 728-740, January 2026.
Abstract Aims This study aimed to evaluate the efficacy and safety of triple therapy with lobeglitazone 0.5 mg as an add‐on treatment compared with placebo in patients with type 2 diabetes mellitus (T2DM) inadequately controlled with metformin and empagliflozin.
Da Hea Seo, Kyung Wan Min, Ho Sang Sohn, Sang Yong Kim, In‐Kyung Jeong, Cheol‐Young Park, Kun‐Ho Yoon, So Hun Kim, Bong‐Soo Cha   +8 more
wiley   +1 more source